UPDATED May 13, 2024
Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
TEVA | US$16.88 | 20.1% | 109.2% | US$19.1b | US$17.34 | PS1.2x | E40.4% | 0% | ||
ALNY | US$149.89 | -0.9% | -27.3% | US$19.0b | US$220.38 | PS9.5x | E64.2% | n/a | ||
ILMN | US$112.77 | -5.2% | -45.0% | US$18.0b | US$156.10 | PS4x | E63.1% | n/a | ||
BGNE | US$162.17 | -0.2% | -32.5% | US$17.0b | US$267.01 | PS6.1x | E60.4% | n/a | ||
RPRX | US$28.38 | -0.4% | -17.3% | US$16.9b | US$45.75 | PE16x | E12.5% | 3.0% | ||
AVTR | US$24.29 | -2.3% | 19.2% | US$16.5b | US$27.77 | PE63.5x | E35.0% | n/a | ||
BMRN | US$80.50 | -1.9% | -15.4% | US$15.3b | US$110.24 | PE74.4x | E29.8% | n/a | ||
NBIX | US$136.15 | -3.9% | 38.7% | US$13.7b | US$157.81 | PE37.1x | E26.3% | n/a | ||
VTRS | US$11.36 | -3.9% | 21.2% | US$13.5b | US$12.33 | PB0.7x | E9.7% | 4.2% | ||
RVTY | US$105.55 | 2.7% | -8.4% | US$13.0b | US$123.61 | PE71x | E26.6% | 0.3% | ||
INCY | US$57.60 | 6.5% | -13.0% | US$12.9b | US$73.35 | PE17.4x | E17.8% | n/a | ||
TECH | US$81.97 | 7.8% | 1.1% | US$12.9b | US$83.64 | PE63.6x | E14.9% | 0.4% | ||
NTRA | US$103.33 | 6.3% | 98.1% | US$12.7b | US$121.63 | PS10.5x | E69.8% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
SRPT | US$131.70 | -2.5% | -16.2% | US$12.4b | US$165.89 | PE736.7x | E37.0% | n/a | ||
MEDP | US$389.27 | -2.9% | 84.6% | US$12.0b | US$423.17 | PE38.5x | E13.8% | n/a | ||
CRL | US$228.41 | -2.9% | 18.7% | US$11.8b | US$265.60 | PE26.5x | E13.6% | n/a | ||
UTHR | US$264.34 | 1.5% | 23.3% | US$11.7b | US$292.74 | PE11.2x | E6.7% | n/a | ||
BRKR | US$74.24 | 2.4% | 2.5% | US$10.8b | US$85.70 | PE26.9x | E6.8% | 0.3% | ||
EXAS | US$55.59 | -12.2% | -31.3% | US$10.3b | US$86.59 | PS4x | E65.9% | n/a | ||
CTLT | US$55.80 | -1.0% | 68.1% | US$10.1b | US$63.50 | PS2.4x | E91.8% | n/a | ||
QGEN | US$44.33 | 4.1% | -5.2% | US$9.8b | US$50.19 | PE29.2x | E12.2% | n/a | ||
RGEN | US$163.34 | -2.8% | 6.0% | US$9.1b | US$204.16 | PE614.9x | E60.5% | n/a | ||
ROIV | US$11.18 | -3.6% | 22.2% | US$9.0b | US$16.11 | PE2.1x | E-52.0% | n/a |